Jazz Pharmaceuticals (JAZZ) Shares Outstanding (Diluted Average) (2010 - 2026)

Jazz Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 17 years deep, the most recent figure standing at $66.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 8.36% year-over-year to $66.1 million; the TTM figure through Mar 2026 stood at $66.1 million (up 8.36% YoY), while the FY2025 annual figure was $61.0 million, down 7.61% from the prior year.
• Shares Outstanding (Diluted Average) was $66.1 million for Q1 2026 at Jazz Pharmaceuticals, up from $61.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $73.8 million in Q1 2023 to a low of $61.0 million in Q3 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $65.9 million across 5 years, with a median of $63.4 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) advanced 17.27% in 2023, then declined 15.23% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $62.5 million in 2022, then increased by 15.23% to $72.1 million in 2023, then fell by 8.41% to $66.0 million in 2024, then dropped by 7.61% to $61.0 million in 2025, then grew by 8.39% to $66.1 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $66.1 million (Q1 2026), $61.0 million (Q4 2025), and $61.0 million (Q3 2025), per Business Quant data.